business
Elan secures restricted Tysabri approval
Irish-based multinational pharmaceutical giant Elan and Nasdaq-quoted Biogen Idec have been given restricted approval by the US Food and Drug Administration (FDA) for the reintroduction of multiple sclerosis drug Tysabri.